Across West Virginia University, we are innovating solutions to the opioid epidemic and the ways it has impacted our state. As an R1 Research Institution, we are breaking new ground for treatment, prevention, educational and economic opportunities, and so much more.
Addiction is a multi-faceted problem, complicated even more by the COVID-19 pandemic, but Mountaineers are rising to the challenge.
Through our efforts, we’re offering help and hope to thousands of families who have been affected.
For the more than 20 million Americans living with addiction, there are many paths to recovery. Researchers at WVU are developing clinical trials, medications and programs to provide hope for individuals, families and communities.Discover how we’re innovating addiction treatment and recovery
The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine have launched a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder.
Addiction is a multifaceted issue and prevention is the key before it becomes a problem. Our researchers are developing and implementing evidence-based prevention programs to eliminate or reduce risk factors for drug use.Learn how we’re using research to prevent addiction
Students at WVU can become involved in helping with the pandemic through courses and support groups.Become involved for a brighter tomorrow
On a statewide level WVU is addressing the issue through new programs to empowering public school teachers with the knowledge to help students.Empower yourself with the tools to help
Substance use goes further than just the immediate risks. Through research, our experts have identified links to HIV, neonatal abstinence syndrome, suicide and other dangerous effects.Find out how we’re identifying additional concerns
Scientists still know little about how opioid overdoses affect the brain and cognition. WVU School of Medicine researchers found that while evidence exists to support a link between overdose, cognitive impairment and brain abnormalities, more research is needed in this area.
Drug use and addiction costs in the U.S. are estimated to be more than $740 billion annually in lost workplace productivity, healthcare expenses and crime-related costs. Researchers at WVU are working to better understand its influence on the economy and implement workforce development programs.Learn how we’re determining workforce impact